QTRX Quanterix Corporation Stock Quote

QTRX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.79	Insider Own	7.10%	Shs Outstand	36.85M	Perf Week	-10.64%
Market Cap	597.56M	Forward P/E	-	EPS next Y	-2.38	Insider Trans	-1.14%	Shs Float	34.25M	Perf Month	1.94%
Income	-65.70M	PEG	-	EPS next Q	-0.49	Inst Own	89.30%	Short Float	3.94%	Perf Quarter	-42.48%
Sales	112.90M	P/S	5.29	EPS this Y	-50.40%	Inst Trans	1.82%	Short Ratio	3.87	Perf Half Y	-60.27%
Book/sh	11.57	P/B	1.45	EPS next Y	-6.20%	ROA	-12.90%	Target Price	39.50	Perf Year	-71.77%
Cash/sh	10.52	P/C	1.60	EPS next 5Y	-	ROE	-14.70%	52W Range	14.58 - 60.95	Perf YTD	-60.40%
Dividend	-	P/FCF	-	EPS past 5Y	-3.30%	ROI	-13.30%	52W High	-72.45%	Beta	1.53
Dividend %	-	Quick Ratio	12.90	Sales past 5Y	44.40%	Gross Margin	53.10%	52W Low	15.16%	ATR	1.23
Employees	460	Current Ratio	13.70	Sales Q/Q	8.80%	Oper. Margin	-59.20%	RSI (14)	46.30	Volatility	4.99% 6.96%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-67.90%	Profit Margin	-58.20%	Rel Volume	0.46	Prev Close	16.19
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 10 BMO	Payout	-	Avg Volume	348.06K	Price	16.79
Recom	1.70	SMA20	-1.31%	SMA50	-10.18%	SMA200	-50.27%	Volume	160,045	Change	3.71%

Mar-02-22

Upgrade

Goldman

Sell → Neutral

$40

Oct-15-21

Resumed

Cowen

Outperform

Jun-04-21

Initiated

Goldman

Sell

$53

Jun-30-22 08:00AM	Quanterix (NASDAQ:QTRX) investors are sitting on a loss of 72% if they invested a year ago Simply Wall St.
Jun-09-22 04:30PM	Quanterix to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Business Wire
Jun-06-22 08:36AM	Quanterix Announces Appointment of Karen A. Flynn to Board of Directors Business Wire
May-10-22 09:05PM	Quanterix Corporation (QTRX) Reports Q1 Loss, Tops Revenue Estimates Zacks -9.08%
08:00AM	Quanterix Corporation Releases Operating Results for First Quarter 2022 Business Wire
May-09-22 05:45PM	BioLife Solutions, Inc. (BLFS) Reports Q1 Loss, Lags Revenue Estimates Zacks -17.96%
May-03-22 08:30AM	Quanterix Corporation to Release First Quarter 2022 Financial Results on May 10, 2022 Business Wire
Apr-27-22 03:03PM	Quanterix Corporation (QTRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks
Apr-22-22 11:56AM	Quanterix Receives FDA Breakthrough Device Tag For NfL Test For Multiple Sclerosis Benzinga
08:30AM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis Business Wire
Apr-04-22 04:30PM	Quanterix Simoa® Technology Powers Large, International Comprehensive Reference Range Study Utilizing Serum Neurofilament Light (sNfL) to Assess Disease Activity in Multiple Sclerosis (MS) Patients Business Wire
Mar-29-22 04:30PM	Quanterix Receives Funding from the Alzheimers Drug Discovery Foundation to Accelerate Alzheimers Disease Diagnostic Plasma Test Development Business Wire +5.62%
Mar-16-22 06:56AM	Here's Why We're Not Too Worried About Quanterix's (NASDAQ:QTRX) Cash Burn Situation Simply Wall St. +6.78%
Mar-09-22 04:30PM	Quanterix to Participate in Barclays Global Healthcare Conference Business Wire
Mar-03-22 04:30PM	Quanterix to Participate in The Cowen 42nd Annual Health Care Conference On March 9 Business Wire
08:12AM	The Petri Dish: Quanterix gets Lilly deal, new CEO; Finch hit by clinical hold American City Business Journals
Mar-01-22 08:55AM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.34%
07:30AM	Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021 Business Wire
07:30AM	Quanterix Announces New Agreements with Lilly to Advance Alzheimers Disease Diagnosis and Treatment Business Wire
07:30AM	Quanterix Announces Executive Leadership Succession Plan Business Wire
Feb-28-22 02:29PM	Quanterix Corporation Garners Five Best Places to Work Awards from Comparably Business Wire
Feb-24-22 06:40PM	LeMaitre Vascular (LMAT) Misses Q4 Earnings and Revenue Estimates Zacks +10.39%
Feb-23-22 04:30PM	Quanterix Corporation to Release Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022 Business Wire
Feb-09-22 09:00AM	Quanterix to Participate in the SVB Leerink Global Healthcare Conference Business Wire +6.56%
Feb-07-22 06:43PM	UK Dementia Research Institute Biomarker Factory Powers Alzheimers Disease Breakthroughs with Quanterix Simoa® Technology Business Wire
Jan-26-22 11:30AM	Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis Business Wire
Jan-13-22 07:30AM	Quanterix Provides Operational and Preliminary Financial Highlights Business Wire
Jan-06-22 04:30PM	Quanterix to Present at 40th Annual J.P. Morgan Healthcare Conference Business Wire
Dec-21-21 06:38AM	Cassava Surges on Claim Another Science Journal Cleared it of Charges Investing.com
Dec-16-21 10:00AM	Recent 4.0% pullback isn't enough to hurt long-term Quanterix (NASDAQ:QTRX) shareholders, they're still up 120% over 3 years Simply Wall St.
Dec-15-21 09:57PM	These 3 Stocks Are Top Picks for 2022, Say Analysts TipRanks
Nov-18-21 08:43AM	Cassava (SAVA) Down on Report of SEC Investigation Into AD Program Zacks -6.13%
Nov-17-21 04:15PM	Quanterix Recognized as a Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500 Business Wire -8.09%
04:53AM	Cassava Slumps on Report SEC Probing Developer of Alzheimers Drug Investing.com
Nov-16-21 09:20AM	Quanterix Simoa® Technology Powers Advances in Alzheimers Disease Research Presented at 2021 Clinical Trials on Alzheimers Disease (CTAD) Conference Business Wire
Nov-11-21 04:30PM	Quanterix to Participate in the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum Business Wire
Nov-08-21 01:21PM	Quanterix Co-Inventor of Simoa® David Walt Receives Kabiller Prize in Nanoscience and Nanomedicine Business Wire
Nov-05-21 01:00PM	Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript Motley Fool
Nov-04-21 04:01PM	Quanterix Corporation Releases Operating Results for Third Quarter of 2021 Business Wire
06:38AM	Cassava Soars as Journal of Neuroscience Backs it on Alzheimers Study Investing.com
Oct-28-21 04:30PM	Quanterix Corporation to Release Third Quarter 2021 Financial Results on Nov. 4, 2021 Business Wire
03:05PM	Analysts Estimate Quanterix Corporation (QTRX) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-26-21 04:54PM	Where Do Hedge Funds Stand On Quanterix Corporation (QTRX)? Insider Monkey
Oct-12-21 12:22PM	30 Stocks Moving In Tuesday's Mid-Day Session Benzinga +13.28%
12:09PM	Why Shares of Quanterix Are Climbing This Morning Motley Fool
07:04AM	15 Stocks Moving in Tuesday's Pre-Market Session Benzinga
Oct-11-21 04:05PM	Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimers Disease Business Wire -5.45%
Oct-06-21 06:55AM	Cassava Sciences Starts Phase 3 Alzheimer's-Drug Study TheStreet.com
Sep-23-21 10:15AM	With Quanterix, I'm Charting Out My Options TheStreet.com +8.49%
Sep-20-21 08:26AM	Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories Business Wire -5.53%
Sep-17-21 12:02PM	Does Quanterix (NASDAQ:QTRX) Have A Healthy Balance Sheet? Simply Wall St. +5.37%
Sep-14-21 07:40AM	FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label Benzinga
Sep-13-21 05:42PM	Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test Business Wire
Sep-10-21 05:28PM	Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: "COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings" Business Wire
Sep-01-21 10:44AM	Biotech Stock Roundup: REGN Gives Study Update, INCY Wins Drug Approval & More Zacks
Aug-30-21 11:43AM	Cassava (SAVA) Down as Quanterix Issues Statement on AD Study Zacks
Aug-27-21 04:26PM	Cassava Sciences punches back, after Qaunterix took a swing by saying it didnt interpret or prepare the disputed trial data MarketWatch +9.44%
04:10PM	Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations Investor's Business Daily
04:09PM	Cassava Sinks After Lab Distances Itself on Alzheimers Data Bloomberg
11:00AM	Why Cassava Sciences Is Plunging Again Today Motley Fool
08:58AM	Cassava's stock tumbles again, after Quanterix said it 'did not' prepare data charts presented by Cassava, that are under dispute MarketWatch
08:19AM	Quanterix Releases Statement Business Wire
07:14AM	Cassava Stock Sinks on Quanterix Denial Over Alzheimer's Drug Test TheStreet.com
Aug-25-21 07:23AM	Cassava Tanks 20% as It Battles Charges Over Scientific Integrity Investing.com
Aug-09-21 04:30PM	Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference Business Wire
Aug-06-21 07:57AM	Quanterix Simoa® Technology Powers Breakthrough Alzheimers Disease Research Presented by Eli Lilly and Company at Alzheimers Association International Conference (AAIC) 2021 Business Wire -8.04%
Aug-05-21 08:15PM	Quanterix Corporation (QTRX) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:18PM	Quanterix Corporation Releases Operating Results for Second Quarter of 2021 Business Wire
Jul-28-21 07:04AM	Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021 Business Wire
Jul-27-21 03:03PM	Will Quanterix Corporation (QTRX) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-21-21 01:53PM	Where Do Hedge Funds Stand On Quanterix Corporation (QTRX)? Insider Monkey
Jun-28-21 04:08PM	Quanterix Appoints Michael Doyle as Chief Financial Officer Business Wire +7.06%
Jun-19-21 05:53AM	We Take A Look At Why Quanterix Corporation's (NASDAQ:QTRX) CEO Compensation Is Well Earned Simply Wall St.
Jun-11-21 02:31PM	Medical Device Maker Quanterix Stock Shows Rising Relative Strength Investor's Business Daily
Jun-07-21 10:13AM	Quanterix Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Lights Role in Dementia Diagnosis Business Wire +10.72%
Jun-02-21 11:02AM	Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report Business Wire
May-11-21 08:00AM	Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics Business Wire
May-07-21 09:15AM	What Type Of Shareholders Own The Most Number of Quanterix Corporation (NASDAQ:QTRX) Shares? Simply Wall St. +6.45%
May-05-21 04:01PM	Quanterix Corporation Releases Operating Results for First Quarter 2021 Business Wire
Apr-28-21 04:30PM	Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021 Business Wire
07:30AM	Quanterix Appoints Laurie Olson to Board of Directors Business Wire
Apr-27-21 02:18PM	Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86 Investor's Business Daily
Apr-22-21 03:29PM	Quanterix Webinar: Recent Advancements in Neurodegenerative Biomarkers: Progress Towards A Diagnostic Blood Test for Alzheimers Disease Business Wire
Apr-21-21 07:10AM	Quanterix Announces Appointment of Interim Chief Financial Officer Business Wire
Mar-26-21 06:47AM	Quanterix Simoa Technology Demonstrates Advancements in COVID-19 Research through Viral Antigen Measurements in Blood and Saliva Samples Business Wire
Mar-17-21 04:01PM	Quanterix Simoa Technology Accelerates Critical Plasma Biomarker Research Presented at the 15th International Conference on Parkinsons & Alzheimers Disease (AD/PDTM 2021) Business Wire
Mar-02-21 05:25PM	Quanterix Corporation (QTRX) Reports Q4 Loss, Tops Revenue Estimates Zacks -6.73%
04:03PM	Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2020 Business Wire
Mar-01-21 10:05AM	Preview: Quanterix's Earnings Benzinga +9.12%
Feb-25-21 06:05PM	Quanterix Kevin Hrusovsky to Present at the Cowen 41st Annual Health Care Conference on March 3 and Appear on the Feb. 26 Episode of the Health Care Rounds Podcast Business Wire -5.62%
Feb-23-21 11:19AM	Quanterix Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021 Business Wire
Feb-18-21 11:59AM	Quanterix to Present at the 10th Annual SVB Leerink Global Healthcare Conference Business Wire
Feb-12-21 02:08PM	Quanterix Announces Simoa® Joint Laboratory with WuXi AppTec Business Wire +7.20%
Feb-09-21 08:41AM	Did Business Growth Power Quanterix's (NASDAQ:QTRX) Share Price Gain of 287%? Simply Wall St.
Feb-08-21 03:12PM	Quanterix Announces Closing of Public Offering Including Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Feb-04-21 07:00AM	Quanterix Prices Public Offering of Common Stock Business Wire +9.67%
Feb-03-21 04:25PM	Quanterix Announces Proposed Public Offering of $200.0 Million of its Common Stock Business Wire
Jan-22-21 03:39PM	Quanterix to Participate in PMWC 2021 COVID-19 Conference Business Wire
Jan-13-21 08:30AM	Quanterix Provides Operational and Preliminary Financial Highlights Business Wire +13.81%
Jan-12-21 03:27AM	Quanterixs Covid-19 Antigen Test Cleared For Emergency Use In US; Shares Pop 10% SmarterAnalyst +12.75%

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testing, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Toloue Masoud	President & CEO	Jun 13	Sale	15.27	5,564	84,955	81,701	Jun 14 04:12 PM
Fry John J	General Counsel & Secretary	Jun 02	Sale	17.47	378	6,605	38,459	Jun 03 04:19 PM
HRUSOVSKY E KEVIN	Executive Chairman	Jun 02	Sale	17.47	712	12,441	911,209	Jun 03 04:19 PM
HRUSOVSKY E KEVIN	Executive Chairman	May 02	Sale	22.36	649	14,515	911,921	May 03 04:34 PM
Fry John J	General Counsel & Secretary	May 02	Sale	22.36	429	9,595	38,837	May 03 04:25 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Apr 01	Sale	29.79	868	25,860	886,976	Apr 05 04:03 PM
Mattoon Dawn	Sr. VP, Diagnostics	Apr 01	Sale	29.79	261	7,776	36,876	Apr 05 04:02 PM
Fry John J	General Counsel & Secretary	Apr 01	Sale	29.79	524	15,611	30,229	Apr 05 04:02 PM
Roskey Mark T.	SVP, Strategic Partnerships	Apr 01	Sale	29.79	171	5,095	22,325	Apr 05 04:03 PM
Duffy David C.	SVP R&D and CTO	Mar 23	Sale	30.00	3,266	97,980	54,730	Mar 28 05:02 PM
Fry John J	General Counsel & Secretary	Mar 01	Sale	31.46	371	11,671	30,753	Mar 03 05:00 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Mar 01	Sale	31.46	589	18,530	887,844	Mar 03 05:01 PM
Roskey Mark T.	SVP, Strategic Partnerships	Mar 01	Sale	31.46	166	5,222	22,496	Mar 03 05:01 PM
Mattoon Dawn	Sr. VP, Diagnostics	Mar 01	Sale	31.46	267	8,399	37,137	Mar 03 05:00 PM
Fry John J	General Counsel & Secretary	Feb 09	Sale	34.97	481	16,820	31,124	Feb 09 05:12 PM
Roskey Mark T.	SVP, Strategic Partnerships	Feb 09	Sale	34.97	292	10,211	22,662	Feb 09 05:13 PM
Mattoon Dawn	Sr. VP, Diagnostics	Feb 09	Sale	34.97	318	11,120	37,404	Feb 09 05:12 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Feb 09	Sale	34.97	1,364	47,697	888,433	Feb 09 05:10 PM
Duffy David C.	SVP R&D and CTO	Feb 04	Sale	30.91	3,266	100,952	57,996	Feb 04 04:01 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Feb 02	Sale	31.46	589	18,530	889,797	Feb 04 04:00 PM
Mattoon Dawn	Sr. VP, Diagnostics	Feb 02	Sale	31.46	267	8,399	37,722	Feb 04 04:00 PM
Roskey Mark T.	SVP, Strategic Partnerships	Feb 02	Sale	31.46	166	5,222	22,954	Feb 04 04:01 PM
Fry John J	General Counsel & Secretary	Feb 02	Sale	31.46	371	11,671	31,605	Feb 04 04:00 PM
Duffy David C.	SVP R&D and CTO	Jan 31	Sale	30.00	3,266	97,980	61,262	Jan 31 04:12 PM
Duffy David C.	SVP R&D and CTO	Jan 03	Option Exercise	2.59	41,246	106,704	64,528	Jan 05 04:04 PM
Mattoon Dawn	Sr. VP, Diagnostics	Jan 03	Sale	41.91	355	14,877	37,989	Jan 05 04:06 PM
Roskey Mark T.	SVP, Strategic Partnerships	Jan 03	Sale	41.91	149	6,244	23,120	Jan 05 04:06 PM
Fry John J	General Counsel & Secretary	Jan 03	Sale	41.91	352	14,751	31,976	Jan 05 04:06 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Jan 03	Sale	41.91	3,715	155,683	890,386	Jan 05 04:06 PM
Duffy David C.	SVP R&D and CTO	Dec 29	Sale	40.71	1,667	67,864	23,282	Dec 30 04:57 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Dec 01	Sale	40.29	3,710	149,477	894,101	Dec 03 04:20 PM
Roskey Mark T.	SVP, Strategic Partnerships	Dec 01	Sale	40.29	147	5,923	23,269	Dec 03 04:19 PM
Fry John J	General Counsel & Secretary	Dec 01	Sale	40.29	350	14,101	32,328	Dec 03 04:18 PM
Mattoon Dawn	Sr. VP, Diagnostics	Dec 01	Sale	40.29	353	14,222	38,344	Dec 03 04:18 PM
Duffy David C.	SVP R&D and CTO	Nov 19	Sale	45.54	1,667	75,915	24,949	Nov 22 06:18 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Nov 10	Sale	55.18	5,000	275,897	897,811	Nov 10 04:06 PM
Mattoon Dawn	Sr. VP, Diagnostics	Nov 05	Option Exercise	19.12	10,718	204,928	47,232	Nov 08 04:26 PM
Mattoon Dawn	Sr. VP, Diagnostics	Nov 05	Sale	57.28	8,535	488,851	38,697	Nov 08 04:26 PM
Mattoon Dawn	Sr. VP, Diagnostics	Nov 04	Sale	57.00	1	57	36,514	Nov 08 04:26 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Nov 02	Sale	52.61	3,505	184,385	902,811	Nov 04 04:19 PM
Roskey Mark T.	SVP, Strategic Partnerships	Nov 02	Sale	52.61	139	7,312	23,416	Nov 04 04:20 PM
Fry John J	General Counsel & Secretary	Nov 02	Sale	52.61	331	17,412	32,678	Nov 04 04:19 PM
Mattoon Dawn	Sr. VP, Diagnostics	Nov 02	Sale	52.61	333	17,518	36,515	Nov 04 04:19 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Oct 22	Sale	50.70	5,000	253,520	906,316	Oct 22 05:48 PM
Duffy David C.	SVP R&D and CTO	Oct 15	Sale	51.47	1,667	85,800	26,616	Oct 19 04:00 PM
Roskey Mark T.	SVP, Strategic Partnerships	Oct 01	Sale	51.20	143	7,322	23,555	Oct 05 04:02 PM
Mattoon Dawn	Sr. VP, Diagnostics	Oct 01	Sale	51.20	342	17,511	36,848	Oct 05 04:02 PM
Fry John J	General Counsel & Secretary	Oct 01	Sale	51.20	340	17,408	33,009	Oct 05 04:02 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Oct 01	Sale	51.20	3,594	184,015	911,316	Oct 04 04:02 PM
HRUSOVSKY E KEVIN	Chairman and CEO	Sep 30	Sale	49.09	5,000	245,449	914,910	Oct 04 04:02 PM
Duffy David C.	SVP R&D and CTO	Sep 22	Sale	47.72	1,667	79,549	28,283	Oct 04 04:09 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Sep 02	Sale	49.66	5,000	248,307	919,910	Sep 03 04:01 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Sep 01	Sale	49.92	3,709	185,158	924,910	Sep 03 04:01 PM
Mattoon Dawn	Sr. VP, Diagnostics	Sep 01	Sale	49.92	353	17,622	37,190	Sep 03 04:01 PM
Fry John J	General Counsel & Secretary	Sep 01	Sale	49.92	350	17,472	33,349	Sep 03 04:01 PM
Roskey Mark T.	SVP, Strategic Partnerships	Sep 01	Sale	49.92	147	7,338	23,698	Sep 03 04:01 PM
Duffy David C.	SVP R&D and CTO	Aug 20	Sale	46.13	1,667	76,899	29,950	Aug 20 04:08 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 16	Sale	47.33	5,000	236,669	928,619	Aug 18 04:19 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Aug 03	Sale	53.79	3,648	196,219	933,619	Aug 03 09:34 PM
Fry John J	General Counsel & Secretary	Aug 03	Sale	53.79	344	18,503	33,699	Aug 03 09:32 PM
Mattoon Dawn	Sr. VP, Diagnostics	Aug 03	Sale	53.79	346	18,611	37,543	Aug 03 09:31 PM
Roskey Mark T.	SVP, Strategic Partnerships	Aug 03	Sale	53.79	145	7,799	23,845	Aug 03 09:29 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jul 29	Sale	54.08	5,000	270,420	937,267	Jul 30 04:39 PM
Duffy David C.	SVP R&D and CTO	Jul 14	Sale	57.77	1,667	96,303	31,617	Jul 14 05:08 PM
HRUSOVSKY E KEVIN	Chairman, President & CEO	Jul 13	Sale	57.45	5,000	287,265	942,267	Jul 14 05:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience